Join
Live feed
·
PRReleasevia Quantisnow
vTv Therapeutics Inc. logo

vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease

ByQuantisnow·Wall Street's wire, on your screen.
VTVT· vTv Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTVT (vTv Therapeutics Inc.) and more on Quantisnow.